Video guest: Josephine Mwangi

December 2017
M T W T F S S
27 28 29 30 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31



SELECT_TAGS :
















Twitter

Follow the CTA Brussels Daily

 

twitter logo

 

facebook logo cta

Wednesday, 03 September 2008

EU Programme to develop avian influenza vaccine

Archimedes Development Ltd, a subsidiary of Archimedes Pharma Ltd, the UK-based pan-European specialty pharmaceutical company, today announced it has received EU funding totalling €2.77 million, over three years, for a collaborative project to reduce the threat of an avian influenza pandemic by developing a vaccine against the avian influenza virus. The Nasal Pandemic Influenza Vaccine (NASPANVAC) project is funded by the European Union under the FP7 scheme.
Source: pharmalive.com